FAC Explorer

Audit 25476

FY End
2022-12-31
Total Expended
$54.98M
Findings
0
Programs
15
Organization: Atcc Global & Subsidiaries (VA)
Year: 2022 Accepted: 2023-05-14
Auditor: Bdo USA LLP

Organization Exclusion Status:

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.RD Microbiology and Infectious Diseases Biological Resource Repository $22.09M Yes 0
93.RD Influenza Reagent Resource (2) $18.61M Yes 0
93.RD Nci Central Repository - Leidos (pass-Through Award) $7.58M Yes 0
93.RD Regent Program for Hiv and Other Infectious Diseases $3.20M Yes 0
97.RD Nbaf-Biorepository Transfer Support (pass-Through Award) $886,309 Yes 0
93.RD In Vitro Assessment of Antimicrobial Activity - Task Order Bo8 $884,350 Yes 0
93.036 Barda Bsip Idiq Direct Award $662,182 Yes 0
93.RD Determining Requirements to Ensure Entities Have Effectively Inactivated Biological Select Agents and Regulated Nucleic Acids $417,181 Yes 0
12.RD Genome-Wide Mapping (gwm) of Host Proteome (by) $363,932 Yes 0
93.RD Molecular Epidemiology Assay Support Direct Award $118,651 Yes 0
93.855 Mutants of Mycobacterium Tuberculosis - Albert Einstein College of Medicine, Inc. $63,612 Yes 0
12.351 Artificial Intelligence Based Predictive Modeling of the Host Microbiome to Improve Vaccine Effectiveness $56,437 Yes 0
12.251 Discovery and Early Preclinical Development of Host-Targeted Antiviral Strategies to Combat Encephalitic Alphaviruse $17,594 Yes 0
93.RD Stabilizing Flavivirus Rna Gentegra $16,133 Yes 0
93.855 Small Molecules for Treating Pan-Coronavirus Infections $15,129 Yes 0

Contacts

Name Title Type
KT4MLLHK99V6 Scott Boller Auditee
7033652754 Leslie Pine Auditor
No contacts on file

Notes to SEFA

Accounting Policies: Expenditures reported on the schedule are reported on Accrual basis of accounting. Such expenditures are recognized following the cost principles contained in Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. De Minimis Rate Used: N Rate Explanation: The Organization has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance.